Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell Katz

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Diabetes Care|July 28, 2004
Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statementGerard Boehm, Judith A Racoosin, Thomas P Laughren, et al.
Human Gene Therapy|August 11, 2021
Development and Application of a Liquid Chromatography-Mass Spectrometry Method for Residual Iodixanol Quantification in AAV-Based Gene Therapy Product DevelopmentYi Pu, Russell Katz, Yunqiu Chen, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 11, 2012
Considerations in the design of clinical trials for cognitive agingEric M Reiman, Roberta Diaz Brinton, Russell Katz, et al.
Expert Review of Neurotherapeutics|December 27, 2014
Charting a path toward combination therapy for Alzheimer's diseaseDiane Stephenson, Dan Perry, Cynthia Bens, et al.
Epilepsia|May 24, 2014
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disordersOrrin Devinsky, Maria Roberta Cilio, Helen Cross, et al.
The AAPS Journal|May 5, 2010
Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified release products: workshop summary reportMei-Ling Chen, Vinod P Shah, Derek Ganes, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 30, 2010
Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified-release products: workshop summary reportMei-Ling Chen, Vinod P Shah, Derek Ganes, et al.
Clinical Therapeutics|January 4, 2011
Challenges and opportunities in establishing scientific and regulatory standards for determining therapeutic equivalence of modified-release products: Workshop summary reportMei-Ling Chen, Vinod P Shah, Derek Ganes, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Coalition Against Major Diseases: Precompetitive Collaborations and Regulatory Paths to Accelerating Drug Development for Neurodegenerative DiseasesDiane Stephenson, Enrique Aviles, Lisa J Bain, et al.
Expert Review of Neurotherapeutics|February 25, 2015
Building a roadmap for developing combination therapies for Alzheimer's diseaseDaniel Perry, Reisa Sperling, Russell Katz, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Diabetes Care|July 28, 2004
Consensus development conference on antipsychotic drugs and obesity and diabetes: response to consensus statementGerard Boehm, Judith A Racoosin, Thomas P Laughren, et al.
Human Gene Therapy|August 11, 2021
Development and Application of a Liquid Chromatography-Mass Spectrometry Method for Residual Iodixanol Quantification in AAV-Based Gene Therapy Product DevelopmentYi Pu, Russell Katz, Yunqiu Chen, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|May 11, 2012
Considerations in the design of clinical trials for cognitive agingEric M Reiman, Roberta Diaz Brinton, Russell Katz, et al.
Expert Review of Neurotherapeutics|December 27, 2014
Charting a path toward combination therapy for Alzheimer's diseaseDiane Stephenson, Dan Perry, Cynthia Bens, et al.
Epilepsia|May 24, 2014
Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disordersOrrin Devinsky, Maria Roberta Cilio, Helen Cross, et al.
The AAPS Journal|May 5, 2010
Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified release products: workshop summary reportMei-Ling Chen, Vinod P Shah, Derek Ganes, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 30, 2010
Challenges and opportunities in establishing scientific and regulatory standards for assuring therapeutic equivalence of modified-release products: workshop summary reportMei-Ling Chen, Vinod P Shah, Derek Ganes, et al.
Clinical Therapeutics|January 4, 2011
Challenges and opportunities in establishing scientific and regulatory standards for determining therapeutic equivalence of modified-release products: Workshop summary reportMei-Ling Chen, Vinod P Shah, Derek Ganes, et al.
Therapeutic Innovation & Regulatory Science|September 22, 2018
Coalition Against Major Diseases: Precompetitive Collaborations and Regulatory Paths to Accelerating Drug Development for Neurodegenerative DiseasesDiane Stephenson, Enrique Aviles, Lisa J Bain, et al.
Expert Review of Neurotherapeutics|February 25, 2015
Building a roadmap for developing combination therapies for Alzheimer's diseaseDaniel Perry, Reisa Sperling, Russell Katz, et al.
Pageof 2